{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-103867","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.043668+00:00","generated_at":"2026-05-31T00:46:07.880217+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Quoin Pharma sets 2024 AGM for Dec 5; shareholder proposals due Oct 10","bullets":["Annual meeting scheduled for December 5, 2024, more than 30 days after last year's anniversary.","Shareholder proposals under Rule 14a-8 must be received by October 10, 2024 for inclusion in proxy.","Universal proxy rule notice for director nominees also due by October 10, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-103867","json":"https://secwatch.observer/filing/0001104659-24-103867.json","markdown":"https://secwatch.observer/filing/0001104659-24-103867.md","text":"https://secwatch.observer/filing/0001104659-24-103867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/0001104659-24-103867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924103867/tm2425163d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:46:07.880217+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}